Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in Autism

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of child and adolescent psychopharmacology

• Publication date

  2015-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1089/cap.2014.0158PMID 26262902PMCID PMC4544820
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serotonin transporter gene alters insula activity to threat in social anxiety disorder

  2014cited by this paper
• The Autism Diagnostic Observation Schedule, Module 4: Revised Algorithm and Standardized Severity Scores

  2014cited by this paper
• Wechsler Abbreviated Scale of Intelligence

  2014cited by this paper
• A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders

  2013cited by this paper
• A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.

  2012cited by this paper
• Standardizing ADOS Domain Scores: Separating Severity of Social Affect and Restricted and Repetitive Behaviors

  2012cited by this paper
• Cognitive profiles for school -age children with Attention-Deficit/Hyperactivity Disorder or with Mathematics Disorder on the Differential Ability Scales -Second Edition (DAS-II)

  2010cited by this paper
• A pharmacogenetic study of escitalopram in autism spectrum disorders

  2009cited by this paper
• Standardizing ADOS Scores for a Measure of Severity in Autism Spectrum Disorders

  2009cited by this paper
• Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

  2009influential reference
• Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients

  2007cited by this paper
• The Repetitive Behavior Scale-Revised: Independent Validation in Individuals with Autism Spectrum Disorders

  2007cited by this paper
• Combining information from multiple sources in the diagnosis of autism spectrum disorders.

  2006cited by this paper
• Investigating the structure of the restricted, repetitive behaviours and interests domain of autism.

  2006cited by this paper
• Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.

  2006cited by this paper
• An open-label trial of escitalopram in pervasive developmental disorders.

  2005influential reference
• Clinical Efficacy of Fluvoxamine and Functional Polymorphism in a Serotonin Transporter Gene on Childhood Autism

  2005cited by this paper
• Factor Analysis of Restricted and Repetitive Behaviors in Autism Using the Autism Diagnostic Interview-R

  2003cited by this paper
• Mullen Scales of Early Learning

  1997cited by this paper
• A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

  1996cited by this paper
• Fluoxetine treatment of children and adults with autistic disorder and mental retardation.

  1992cited by this paper
• The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

  1985influential reference
• Autistic disturbances of affective contact.

  1968cited by this paper

• Update on pharmacogenomic approaches in the treatment of autism spectrum disorders.

  2026cites this paper
• Autism spectrum disorder and the role of nuclear hormone receptors: insights and therapeutic implications

  2025cites this paper
• Psychopharmacological management of obsessive–compulsive behaviour in children and adolescents with autism spectrum disorders: a narrative review

  2024cites this paper
• Off-label psychopharmacological interventions for autism spectrum disorders: strategic pathways for clinicians

  2023cites this paper
• Systematic Review and Meta-analysis: Pharmacological and Non-Pharmacological Interventions for Persistent Non-episodic Irritability.

  2022cites this paper
• Farmacogenómica en psiquiatría de niños y adolescentes: Una revisión del estado actual de la cuestión

  2021cites this paper
• Pharmacogenomic Studies in Intellectual Disabilities and Autism Spectrum Disorder: A Systematic Review

  2020influential citation
• Effect of Fluoxetine on Obsessive-Compulsive Behaviors in Children and Adolescents With Autism Spectrum Disorders: A Randomized Clinical Trial.

  2019cites this paper
• Artificial Intelligence and Pharmacogenomics

  2019cites this paper
• Differential serotonin transporter (5‐HTT) and 5‐HT2 receptor density in limbic and neocortical areas of adults and children with autism spectrum disorders: implications for selective serotonin reuptake inhibitor efficacy

  2019cites this paper
• Neurodevelopmental roles and the serotonin hypothesis of autism spectrum disorder

  2019cites this paper
• Pharmacogenomics of autism spectrum disorder.

  2017cites this paper
• Lurasidone for the treatment of irritability and anger in autism spectrum disorders

  2017cites this paper
• Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder

  2015cites this paper